haMSter: a Novel Smartphone Communication Tool for People With MS
haMSter: a Novel Smartphone Communication Tool for People With MS
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- haMSter smartphone app
What it measured
Main measures
adherence to device
over the course of this study (over 6 months)
Quality of life (reported by participants)
Other measures (2)
Overall satisfaction with this application in telemedicine
after study completion (after 6 months)
Quality of life (reported by participants)General satisfaction with specific Features of the haMSter app
after study completion (after 6 months)
Quality of life (reported by participants)
Who could take part
MS (type not specified)
Show the full criteria
Inclusion criteria
* Any MS according to MacDonald criteria * informed consent
Exclusion criteria
- language barriers
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
haMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs) in people multiple sclerosis (MS). In this study, 50 patients with MS will receive this app for 6 months and be asked to fill out the PRO questionnaires on their Smartphone. Endpoints include the adherence to this app and satisfaction with this Intervention.
Papers
Results
Altmann P, Ponleitner M, Monschein T, Krajnc N, Zulehner G, Zrzavy T, Leutmezer F, Rommer PS, Kornek B, Berger T, Bsteh G. Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial. Digit Health. 2022 Nov 4;8:20552076221135387. doi: 10.1177/20552076221135387. eCollection 2022 Jan-Dec.Results
Altmann P, Hinterberger W, Leutmezer F, Ponleitner M, Monschein T, Zrzavy T, Zulehner G, Kornek B, Lanzenberger R, Berek K, Rommer PS, Berger T, Bsteh G. The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study. JMIR Res Protoc. 2021 May 7;10(5):e25011. doi: 10.2196/25011.
Loading reviews and guidelines…
History
Started
Apr 2020
Main results due
Apr 2021
Finished
Jun 2021